Cross-sectional evaluation of the impact of information on flexible extended regimens of oral contraceptives in the choices made by women seeking contraceptive counselling: the FLEXO study

References

• Guilbert E, Boroditsky R, Black A, et al. Canadian consensus guideline on continuous and extended hormonal contraception, 2007. J Obstet Gynaecol Can. 2007;29:S1.
   PubMedGoogle Scholar
• Sulak PJ, Kuehl TJ, Coffee A, et al. Prospective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimen. Am J Obstet Gynecol. 2006;195:935–941.
   PubMed Web of Science ®Google Scholar
• Anderson FD, Hait H, Seasonale 3, Study G. A multicenter, randomized study of an extended cycle oral contraceptive. Contraception. 2003;68:89–96.
   PubMed Web of Science ®Google Scholar
• Jensen JT, Garie SG, Trummer D, et al. Bleeding profile of a flexible extended regimen of ethinylestradiol/drospirenone in US women: an open-label, three-arm, active-controlled, multicenter study. Contraception. 2012;86:110–118.
   PubMed Web of Science ®Google Scholar
• Klipping C, Duijkers I, Fortier MP, et al. Contraceptive efficacy and tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study. J Fam Plann Reprod Health Care. 2012;38:73–83.
   PubMed Web of Science ®Google Scholar
• Klipping C, Duijkers I, Fortier MP, et al. Long-term tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study. J Fam Plann Reprod Health Care. 2012;38:84–93.
   PubMed Web of Science ®Google Scholar
• Strowitzki T, Kirsch B, Elliesen J. Efficacy of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen in women with moderate-to-severe primary dysmenorrhoea: an open-label, multicentre, randomised, controlled study. J Fam Plann Reprod Health Care. 2012;38:94–101.
   PubMed Web of Science ®Google Scholar
• Moos MK, Bartholomew NE, Lohr KN. Counseling in the clinical setting to prevent unintended pregnancy: an evidence-based research agenda. Contraception. 2003;67:115–132.
   PubMed Web of Science ®Google Scholar
• Sánchez-Borrego R, García-Calvo C. Spanish women’s attitudes towards menstruation and use of a continuous, daily use hormonal combined contraceptive regimen. Contraception. 2008;77:114–117.
   PubMed Web of Science ®Google Scholar
• Lete I, Doval JL, Pérez-Campos E, et al. Factors affecting women’s selection of a combined hormonal contraceptive method: the TEAM-06 Spanish cross-sectional study. Contraception. 2007;76:77–83.
   PubMed Web of Science ®Google Scholar
• Bitzer J, Cupanik V, Fait T, et al. Factors influencing women’s selection of combined hormonal contraceptive methods after counselling in 11 countries: results from a subanalysis of the CHOICE study. Eur J Contracept Reprod Health Care. 2013;18:372–380.
   PubMed Web of Science ®Google Scholar
• Lete I, Pérez-Campos E. Differences in contraceptive use between Spanish female healthcare providers and Spanish women in the general population aged 23 to 49 years: the HABITS Study. Eur J Contracept Reprod Health Care. 2014;19:161–168.
   PubMed Web of Science ®Google Scholar
• Lete I, Barbadillo N, Ugarte L, et al. A cross-sectional study of the choice of oral estrogen contraceptives in women seeking contraceptive counseling: what type of pill do women prefer after being counseled. Gynecol Obstet. 2015;5:1000321.
   Google Scholar
• Calaf J, Sánchez-Borrego R, Pérez-Campos E, et al. Multicenter, cross-sectional study about the beliefs and attitudes of Spanish women regarding the new oral contraceptives containing natural oestradiol. Creacion study. Rev Iber Fertil Reprod Hum 2012;29:151–158.
   Google Scholar
• Maguire K, Westhoff C. The state of hormonal contraception today: established and emerging noncontraceptive health benefits. Am J Obstet Gynecol. 2011;205:S4–S8.
   PubMed Web of Science ®Google Scholar
• Fruzzetti F, Paoletti AM, Lombardo M, et al. Attitudes of Italian women concerning suppression of menstruation with oral contraceptives. Eur J Contracept Reprod Health Care. 2008;13:153–157.
   PubMed Web of Science ®Google Scholar
• Wiegratz I, Hommel HH, Zimmermann T, et al. Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives. Contraception. 2004;69:37–42.
   PubMed Web of Science ®Google Scholar
• Mendoza N, Lobo P, Lertxundi R, et al. Extended regimens of combined hormonal contraception to reduce symptoms related to withdrawal bleeding and the hormone-free interval: a systematic review of randomised and observational studies. Eur J Contracept Reprod Health Care. 2014;19:321–339.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Fiala C, Chabbert-Buffet N, et al. Women’s preferences for menstrual bleeding frequency: results of the Inconvenience Due to Women’s Monthly Bleeding (ISY) survey. Eur J Contracept Reprod Health Care. 2016;21:242–250.
   PubMed Web of Science ®Google Scholar
• Fiala C, Chabbert-Buffet N, Häusler G, et al. Women’s preferences for menstrual bleeding frequency in 12 European countries: the Inconvenience Due to Women’s Monthly Bleeding (ISY) survey. Eur J Contracept Reprod Health Care. 2017;22:268–273.
   PubMed Web of Science ®Google Scholar
• Lete I, Lobo P, Nappi RE, et al. Male perception about the inconveniences associated with monthly bleeding for their partner – an international survey. Eur J Contracept Reprod Health Care. 2018;23:1–11.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Lete I, Lee LK, et al. Real-world experience of women using extended-cycle vs monthly-cycle combined oral contraception in the United States: the National Health and Wellness Survey. BMC Women’s Health. 2018;18:22.
   PubMed Web of Science ®Google Scholar
• Caruso S, Iraci Sareri M, Agnello C, et al. Conventional vs. extended‐cycle oral contraceptives on the quality of sexual life: comparison between two regimens containing 3 mg drospirenone and 20 µg ethinyl estradiol. J Sex Med. 2011;8:1478–1485.
   PubMed Web of Science ®Google Scholar
• Caruso S, Malandrino C, Cicero C, et al. Quality of sexual life of women on oral contraceptive continued-regimen: pilot study. J Sex Med. 2013;10:460–466.
   PubMed Web of Science ®Google Scholar
• Wiegratz I, Galiläer K, Sänger N, et al. Prescribing preferences and personal experience of female gynaecologists in Germany and Austria regarding use of extended-cycle oral contraceptives. Eur J Contracept Reprod Health Care. 2010;15:405–412.
   PubMed Web of Science ®Google Scholar
• Andrist LC, Arias RD, Nucatola D, et al. Women’s and providers’ attitudes toward menstrual suppression with extended use of oral contraceptives. Contraception. 2004;70:359–363.
   PubMed Web of Science ®Google Scholar
• Seval DL, Buckley T, Kuehl T, et al. Attitudes and prescribing patterns of extended-cycle oral contraceptives. Contraception. 2011;84:71–75.
   PubMed Web of Science ®Google Scholar